Exercise to improve the wellbeing of vulnerable people in Bradford
The Digital Health Enterprise Zone are working with the Bradford Bulls Foundation to support Bradford’s vulnerable communities. Continue reading >>>
University awarded Small Business Charter status and praised for supporting businesses and students
‘School of Management is vital part of local economy and community’ says CEO
University of Bradford’s School of Management has been granted Small Business Charter status for its outstanding work with local businesses and creating employment opportunities for students.
The Small Business Charter is an award for the UK’s world-class business schools. It celebrates business schools that play an effective role in supporting small businesses, local economies and student entrepreneurship and is only granted after rigorous assessment.
Professor Sankar Sivarajah, Head of the School of Management, said he was thrilled by the news.
COVID vaccine supply is causing an EU crisis – so what’s being done to speed up production?
Dr Liz Brien, Director of DHEZ co-authors this atricle from The Conversation
The EU has a vaccine shortage problem. AstraZeneca pledged earlier this month to supply 2 million doses a week to the UK, but has also said it will cut deliveries to the EU from 80 million doses to 31 million during the first quarter of 2021.
New Digital Health Enterprise Zone director sets out bold plan for cutting edge research and teaching
Specialist centre generates state of the art research to advance the digital health agenda
‘World first’ as mass Covid-19 vaccine trial begins in Bradford
Type of Project: NHS use of office space
Project Lead: Helen Horsman
Project Summary: DHEZ hosting one of the world’s first mass Covid-19 vaccine trials
US biotechnology company Novavax worked with Bradford Institute for Health Research (BIHR), part of the Bradford Teaching Hospital NHS Foundation Trust. (BTHFT), to begin trials for a Covid-19 vaccine in the DHEZ.
The trial involves 500 recruits (and another 600 at a site in Leeds), with 50 people given the vaccine per day. Volunteers are given two doses of the vaccine, one on their first day and a second on day 21. They will then be monitored for 12 months. A total of 10,000 people will take part in the ‘Phase 3’ trial, including at other sites, across the UK.